KSHV genome and recombinant DNA technology, we inserted stop codons into the gH coding region. We used 32 electron microscopy to reveal that the gH-null mutant virus assembled and exited from cells normally, 33 compared to wild-type virus. Using purified virions, we assessed infectivity of the gH-null mutant in diverse 34 mammalian cell types in vitro. Unlike wild-type virus or a gH-containing revertant, the gH-null mutant was 35 unable to infect any of the epithelial, endothelial, or fibroblast cell types tested. However, its ability to infect B 36 cells was equivocal, and remains to be investigated in vivo due to generally poor infectivity in vitro. Together, 37 these results suggest that gH is critical for KSHV infection of highly permissive cell types including epithelial, 38 endothelial, and fibroblasts. 39
Michael Brehm e , and Javier Gordon Ogembo a determine the role of KSHV gH in cell entry, replication, and virus egress, we generated ORF22 (gH)-null 126 recombinant KSHV tagged with enhanced green fluorescent protein (rKSHV∆gH-eGFP) and its revertant 127 (rKSHVgH-eGFP Rev) based on wild-type eGFP-tagged recombinant KSHV (rKSHV WT-eGFP) within the E. 128 coli strain GS1783. A sequence of three stop codons, TAGTTAGATAGT (a three-stop element that ensures 129 protein translation machinery encounters a stop signal in all possible three reading frames), was inserted (∆gH) 130 or removed again after insertion (gH Rev) into the gH coding sequence of the rKSHV WT-eGFP genome using 131 the two-step En passant markerless Red recombination system as described (15, 52) . Because the gH gene 132 overlaps with flanking sequences ORF21 and ORF23, the three-stop element was inserted downstream of the 133 gH start codon at amino acid (aa) position 78 to avoid interference with the expression of the upstream ORF21 134 gene (FIG. 1A) . During En passant mutagenesis, we confirmed insertion (step 1) and deletion (step 2) of a 135 kanamycin resistance (Kan R ) gene cassette within the rKSHV WT-eGFP genome using PCR with flanking 136 primers (ORF22-F and ORF22-R, listed in Table 1 ) (FIG. 1B) and restriction fragment length polymorphism 137 analysis with HindIII restriction enzyme (FIG. 1C) . We confirmed the sequence integrity of the mutation site in 138 rKSHV∆gH-eGFP and rKSHVgH-eGFP Rev using Sanger sequencing (FIG. 1D) . The complete genome 139 sequence of rKSHV∆gH-eGFP following the mutagenesis procedure was identical to its parental rKSHV WT-140 eGFP clone, as confirmed using both Illumina Miseq and PacBio genome sequencing. 141
To obtain efficient and stable producer cell lines for rKSHV∆gH-eGFP or rKSHVgH-eGFP Rev, we 142 used inducible SLK (iSLK) cells, a KSHV cell line containing a stable doxycycline (Dox)-inducible cassette of 143 ORF50 (RTA) (15), a KSHV immediate-early gene that is necessary and sufficient for activating KSHV lytic 144 replication. We transfected, selected, and characterized iSLK cells as described (15) . Briefly, we transfected 145 genomic DNAs of rKSHV∆gH-eGFP or rKSHVgH-eGFP Rev into iSLK cells, then selected transfected cells 146 for hygromycin resistance (a gene located within the rKSHV-eGFP genome) until cells in the culture were all 147 on July 10, 2019 by guest http://jvi.asm.org/
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Target Journals: JVI 9 stably eGFP-positive (FIG. 2A) . Upon successful establishment of latency, we expanded the parental iSLK 148 rKSHV WT-eGFP and stable iSLK rKSHV∆gH-eGFP and iSLK rKSHVgH-eGFP Rev cell lines, then treated 149 them with Dox and sodium butyrate (NaB) to induce RTA expression. This led to the initiation of lytic gene 150 expression and subsequent production of rKSHV WT-eGFP, rKSHV∆gH-eGFP, or rKSHVgH-eGFP Rev 151 progeny virions, which we purified from the cell culture supernatants as described (15) . We quantified the 152 purified virions using qPCR and observed that induction of iSLK cells harboring the KSHV gH-null mutant or 153 its revertant consistently released equal titers of virions compared to rKSHV WT-eGFP (FIG. 2B) . We further 154 confirmed the abrogation of gH expression in purified rKSHV∆gH-eGFP virions using immunoblot with an 155 anti-gH monoclonal antibody (mAb) (clone 54A1, unpublished antibody generated in our laboratory) (FIG. 2C,  156 top panel). In our hands, we found that gH expression is typically low in the KSHV-infected cells; thus, to 157 detect gH protein in immunoblots, we used highly purified and concentrated samples of iSLK rKSHV WT-158 eGFP, rKSHV∆gH-eGFP, and rKSHVgH-eGFP Rev virions. We did not detect gH protein in lysates from 159 purified rKSHV∆gH-eGFP virions, but did detect it in all three positive controls, i.e., lysates from purified 160 rKSHV WT-eGFP and rKSHVgH-eGFP Rev virions and purified soluble gH/gL protein complex. As expected, 161
we did not detect gH protein expression in lysates made from iSLK cells (negative control). To confirm that all 162 three recombinant viruses were undergoing normal latent and lytic cycles, we demonstrated the presence of 163 ORF73 (LANA1; a latent KSHV protein) and K8.1 (a lytic KSHV protein) in lysates from all recombinant cell 164 types, but not iSLK negative control cells (FIG. 2C, middle and bottom panel) . 165 166 gH is dispensable for production and egress of KSHV virions. To assess whether KSHV gH is critical for 167 production or egress of virions from stable iSLK rKSHV∆gH-eGFP cells, we seeded equal amounts of iSLK 168 rKSHV WT-eGFP, iSLK rKSHV∆gH-eGFP, or iSLK rKSHVgH-eGFP Rev cells and induced them with Dox 169 and NaB for 48 h. To assess virion production, we washed and fixed the induced cells, prepared thin sections, 170 and observed them using transmission electron microscopy (TEM), confirming that virions produced from 171 on July 10, 2019 by guest http://jvi.asm.org/ Downloaded from Target Journals: JVI   10 rKSHV WT-eGFP, rKSHV∆gH-eGFP, and rKSHVgH-eGFP Rev viruses were assembled within iSLK cells 172 (FIG. 3, top panel) . To assess egress, we filtered and concentrated the supernatant from the induced cells, then 173 performed negative stain TEM, which confirmed that virions produced from all viruses were released into the 174 supernatant (FIG. 3, bottom panel) . These results indicate that KSHV gH is not required for maturation, 175 assembly, or egress of the virus from iSLK cells. 176 177 KSHV gH is indispensable for cell-free viral infection of diverse highly permissive cell lines and primary 178 fibroblasts. We used purified rKSHV WT-eGFP, rKSHV∆gH-eGFP, or rKSHVgH-eGFP Rev virions to 179 determine infectivity and in vitro host range in various cell types. To assess infectivity in iSLK cells, we 180 incubated cells with purified rKSHV WT-eGFP, rKSHV∆gH-eGFP, or rKSHVgH-eGFP Rev virions. Unlike 181 iSLK cells incubated with rKSHV WT-eGFP or rKSHVgH-eGFP Rev, iSLK cells incubated with rKSHV∆gH-182 eGFP were not permissive to infection, even in the presence of infection enhancers such polybrene and/or 183 spinoculation (FIG. 4) . 184
To assess infectivity in other cell types permissive to KSHV infection (24, 53), we incubated iSLK cells 185 (a mixture of endothelial and epithelial cells), human epithelial cell lines (HEK-293 and HeLa), human 186 endothelial cells (HUVEC), and human fibroblasts (HFF-1 cell line and primary tonsil fibroblasts) with purified 187 rKSHV WT-eGFP, rKSHV∆gH-eGFP, or rKSHVgH-eGFP Rev virions. As expected, rKSHV WT-eGFP and 188 rKSHVgH-eGFP Rev infected all cell types tested, as determined using both flow cytometry and microscopy 189 for eGFP expression (FIG. 5A) . We obtained similar results in primary tonsil fibroblasts from four independent 190 donors (FIG. 5B) . In contrast, no infection was observed when any of these cell types were incubated with 191 purified rKSHV∆gH-eGFP, indicating that gH protein is required for infectivity of these highly permissive cell 192 types tested (FIG. 5A-B eGFP, and rKSHVgH-eGFP Rev infected the cells (FIG. 5C) , albeit to a limited extent. This suggests that gH is 197 not required for infection of this cell line or that KSHV can bypass the canonical receptors to cause infection of 198 MC116 cells. We used fluorescent microscopy to further confirm the infectivity of rKSHV 199 rKSHV∆gH-eGFP, and rKSHVgH-eGFP Rev for MC116 cells (FIG. 5D) . Quantification of eGFP-positive 200 infected cells confirmed that infectivity of rKSHV∆gH-eGFP was comparable to that of rKSHV WT-eGFP and 201 rKSHVgH-eGFP Rev (FIG. 5E, top panel) . Furthermore, when we used fluorescence-activated cell sorting 202 (FACS) to enrich for eGFP-positive cells, the resulting cells were able to multiply and spontaneously go lytic, 203 as evidenced by detection of the lytic protein, K8.1, by immunoblot (FIG. 5E, bottom panel) . This suggests that 204 most MC116 infected cells are lytic in nature. We also detected expression of both LANA1 and K8.1 using real-205 time quantitative PCR (RT-qPCR), which was comparable between rKSHV WT-eGFP-and rKSHV∆gH-eGFP-206 infected cells (FIG. 5F) . 207
To confirm that most of the human cell lines tested expressed the canonical cellular receptors that have 208 been implicated in supporting KSHV infection through gH/gL interactions, we analyzed expression of EphA2 209 and EphA4 using immunoblot, and expression of EphA7 using flow cytometry, due to lack of an antibody that 210 works for immunoblot. All of the cell types tested by immunoblotting expressed both EphA2 and EphA4 211 proteins, with the exception of MC116 cells, which only expressed EphA4 (FIG. 5G) HUVEC, HFF-1, and MC116) with rKSHV WT-eGFP or rKSHV∆gH-eGFP at the indicated input 226 concentrations (Log1-Log4 viral copies per cell, as quantified by qPCR), then washed them to remove unbound 227 virus. We used qPCR to quantify total DNA isolated from cell-bound KSHV, viral genome copy number (using 228 To gain an improved understanding of KSHV entry and infection mechanisms, we generated a stable 253 iSLK rKSHV∆gH-eGFP producer cell line that enabled us to fully characterize the phenotype of rKSHV 254 lacking gH expression. Upon lytic induction of iSLK rKSHV∆gH-eGFP cells, normal mature virus particles 255 assembled and were released, indicating that gH is not required for KSHV maturation, assembly, or egress. 256
Although our results contradict a recent observation that deletion of gH is deleterious to viral replication (60), 257
we are confident in the results of our transmission electron microscopy studies, which showed that, as for most 258 other herpesviruses, deletion of KSHV gH does not interfere with viral replication, maturation, or egress. 259
Similar to an EBV gH-null mutant virus (39), we showed that rKSHV lacking gH expressed both latent 260 (LANA1) and lytic (K8.1) genes, indicating that the viral replication cycle is not impaired. We further used the 261 purified, functional, cell-free viral particles to define the role of gH in de novo infection and determine KSHV 262 host range in vitro. Our results show that KSHV gH is indispensable for infection of human and non-human 263 epithelial cells, endothelial cells, and fibroblasts; however, because we observed low efficiency of infection to 264 the MC116 B cell line, we consider its role in human B cell infection to remain inconclusive. This is further 265 confirmation that deletion of KSHV gH is not deleterious to viral replication. 266 To counter the challenges inherent in targeting host cell receptors to prevent KSHV infection, we 291 suggest that targeting multiple viral glycoproteins involved in viral entry may be more effective. Our study 292 provides strong evidence that expression of KSHV gH is absolutely required for infection of epithelial cells, 293 endothelial cells, and fibroblasts. Although KSHV lacking gH was capable of binding to these cell types, it did 294 not infect them, even at high viral DNA copy number. Coupled with published data on EphA2/A4 knockout, 295 this suggests that the gH/gL complex interacts with more than two host cell receptors engaged in viral infection 296 in epithelial, endothelial, and fibroblast cells (35). Recent isolation of broadly neutralizing mAbs against other 297 herpesviruses such as EBV gH/gL (AMMO1) (68), or human cytomegalovirus gH/gL pentameric complex (69), 298 suggests that such antibodies may exist for KSHV and that KSHV gH/gL may be useful targets for developing 299 prophylactic vaccines to elicit broadly neutralizing antibodies to prevent infection in epithelial, endothelial, and 300 fibroblast cells. 301
Despite remarkable progress made in elucidating general γ-herpesvirus entry mechanisms into highly 302 permissive cell types, how KSHV enters B cells both in vitro and in vivo remains unresolved. In striking 303 contrast to the abrogated infection we observed in epithelial cells, endothelial cells, and fibroblasts, and to its 304 closest related human γ-herpesvirus, EBV (39), our gH-null KSHV mutant infected a well-characterized 305 permissive B cell line (MC116) in vitro to a limited extent. This infection was characterized by lytic induction, 306 as evidenced by readily detectable K8.1 protein without artificial induction of lytic replication using chemical 307 reagents. Given our preliminary observations that gH-null virus was infectious to B cells, we speculate that 308 KSHV entry into B cells likely occurs through another envelope glycoprotein, K8.1, and its binding to a yet-to-309 be determined receptor, as was recently reported (54). The importance of K8.1 for B cell infection was recently 310 demonstrated by Dollery at el; their group showed that blocking K8.1 with mAbs or a K8.1-null mutant 311 rKSHV∆K8.1 (45, 70) However, elucidating the role of KSHV gB in infection is not straightforward. Using a BAC system, a previous 316 study demonstrated that KSHV gB-null mutant virus can replicate, but that its virions neither mature nor egress 317 outside of host cells to release infectious particles, making it difficult to test the ability of rKSHV lacking gB 318 protein to infect cells (44). Thus, future studies could explore the use of a protease-sensitive gB mutant or gB-319 neutralizing antibodies as an alternative strategy to elucidate the role(s) of gB in viral entry and identify its 320 receptor in B cells. However, to our knowledge, there are currently no such reagents available to fully 321 characterize the phenotype of a KSHV gB-null mutant virus. Regarding B cell entry via gH/gL, our findings 322 and current cumulative evidence suggest that the gH/gL-EphA2 interaction does not play any role in the 323 infection of B cells, given that EphA2 is not expressed on most B cells (26, 66, 71) . However, our results 324
showed for the first time that MC116 cells express both EphA4 and EphA7, both of which have been implicated 325 in KSHV infection, either through cell-free viral infection or cell-to-cell transmission (33, 34). These receptors 326 may provide a mechanism for KSHV entry and infection of B cells or other cell types; however, their roles 327 remain to be elucidated. 328
In summary, this work highlights the utility of the BAC system and Red recombination technique in 329 dissecting the functional role of KSHV gH protein in viral replication and de novo infection of a variety of 330 target cells. We provide evidence that KSHV gH is not required for viral maturation, virion assembly, or egress, 331 and that it is indispensable for infection of epithelial cells, endothelial cells, and fibroblast cells. Thus, we 332 suggest that gH is a key target for the development of prophylactic vaccines to prevent initial KSHV infection. 333
However, the role of gH in B cell infection remains inconclusive, and we will continue to investigate this role in 334 our laboratory in a humanized BLT (bone marrow, liver, and thymus) mouse model generated from 335 NOD/SCID/IL2rγ mice, which have been shown to be susceptible to KSHV infection and to develop KSHV-336 positive B cell lymphoma (72). We expect results from the present and future studies to fully inform 337 Frederick, MD). iSLK cells were cultured with 2 mM L-glutamine, 10% FBS, and 1% penicillin/streptomycin 355 antibiotics in DMEM medium supplemented with 1 µg/ml puromycin and 250 µg/ml G418. All cell lines were 356 cultured at 37°C in a humidified, 5% CO 2 incubator. 357
De-identified primary human tonsil fibroblasts were obtained after routine tonsillectomy from discarded, Diego, CA). The resulting single-cell suspensions were cultured as mixed lineage, high-density cultures in 364 endothelial cell media containing 100 µg/ml antimicrobial Primocin (InvivoGen, San Diego, CA) for 7-10 days 365 to facilitate adaptation to 2-dimensional cell culture. Fibroblasts were then isolated from adapted cultures using 366 positive selection via magnetic microbeads (CD90 microbeads 130-096-253; Miltenyi). After isolation, primary 367 CD90+ fibroblasts were maintained in DMEM containing 10% FBS and Primocin, and were used for 368 experiments between passage 3 and 10. 369
370
Plasmids and mutagenesis of KSHV WT-eGFP genome. To generate plasmid for qPCR standardization, full-371 length WT K8.1 was individually cloned into the pCAGGS mammalian expression vector as described (73). To 372 construct gH/gL Fc-6xHis-tagged plasmids for protein production, a single transcript expressing WT gL (gL-373 WT; aa 1-139) and the gH ectodomain (aa 1-702) was synthesized by Genewiz (South Plainfield, NJ). The 374 upstream (5') and downstream (3') sequences contained NotI and SpeI enzyme restriction sites, respectively 375 (74), which were used to subclone the synthesized product into the Cntn1-Fc-His vector, a gift from Dr. 376
Wojtowicz, Stanford University, CA (Addgene plasmid #72065). To express gH/gL complex in its native form, 377 a unique 2A linker sequence (18 aa) (75) was interspersed between the cDNAs encoding for the two proteins. 378
This resulted in a polycistronic vector with a cleavage site that allows gL-WT and the gH ectodomain to be 379 processed independently after transcription, and released to natively form a complex that is released into the 380 supernatant. Sanger sequencing was used to verify the fidelity of the whole vector and the construct. 381 pEPkan-S plasmid was used as a source of the Kan R gene cassette required for En Passant mutagenesis 382 (12). rKSHV WT-eGFP within the E. coli strain GS1783 was a kind gift of Dr. Jung (15). rKSHV WT-eGFP 383 was used as a vector in which three stop codons (TAGTTAGATAGT) were introduced within ORF22 (gH) at 384 nucleotide position 37,165 using En Passant mutagenesis, a two-step, markerless Red recombination technique, 385 on July 10, 2019 by guest http://jvi.asm.org/
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Target Journals: JVI 19 as described (15, 52) . This resulted in a truncated sequence devoid of gH protein expression. The cloning 386 mutagenesis strategy and the primers used for insertion (to make rKSHV∆gH-eGFP) and removal (to make 387 rKSHVgH-eGFP Rev) of the three-stop element are illustrated in FIG. 1A and Table 1 . Recombinant clones 388 with insertion or deletion of the Kan R cassette in the rKSHV WT-eGFP genome following the two-step Red 389 recombination technique were digested with HindIII, and the site of mutation was PCR-amplified using primers 390 flanking the region and analyzed by agarose-gel electrophoresis. The mutated sites of each rKSHV WT-eGFP 391 clone and the integrity of the whole genome were confirmed using Sanger sequencing and next-generation 392 sequencing, respectively. 393
394
Whole genome sequencing and sequence analysis. Genome sequencing of the purified rKSHV∆gH-eGFP 395 DNA from GS1783 bacteria was performed using standard protocols, as described (15) Madison, WI) (12). Transfected cells were selected in media containing hygromycin at a final concentration of 419 1 mg/ml, which was also used to maintain stable iSLK cell lines harboring latent KSHV. To produce the 420 progeny virus, these stable cell lines were expanded into 100 T-175 flasks, induced by addition of 2 µg/ml Dox 421 and 1.5 mM of NaB to the culture media, and incubated for 24 h, after which the induction media was removed 422 and cells were cultured in complete DMEM for four days as described (15). Progeny virus particles in the 423 harvested cell culture supernatant were clarified twice by centrifugation at 2,000 ×g for 15 min, followed by 424 filtration through a 0.8 µm membrane to remove cellular debris. Virions were pelleted by ultra-centrifugation 425 pCAGGS-K8.1 (73) or pCR2.1-GFP was used as a standard for absolute quantification of viral genome copies. 438
The sequences of reverse transcriptase qPCR primer sets for amplification of viral ORF targets are provided in 439 Table 1 . 100% Eponate and polymerized at 64°C for 48 h. Ultra-thin sections (~70 nm thick) were cut using a Leica 449 Ultracut UCT ultramicrotome (Wetzlar, Germany) with a diamond knife and picked up on 200-mesh copper 450 TEM grids. Grids were stained with 2% uranyl acetate for 10 min, followed by Reynold's lead citrate staining 451 for 1 min. To perform negative stain TEM of extracellular progeny virus particles, the harvested supernatant 452 was clarified by centrifugation at 2,000 ×g for 15 min, followed by filtration through 0.8 µm membrane to 453 remove cellular debris. Purified virions were pelleted using ultra-centrifugation through a 5% Optiprep gradient 454 at 10,000 ×g, 70 min, 4°C, then fixed in 2% glutaraldehyde and processed for TEM. Briefly, individual purified 455 virions were resuspended in 1x PBS and solution was adsorbed to glow-discharged, carbon-coated 300 mesh 456 were added to the TRIzol and RNA was isolated using a Zymo Directzol RNA miniprep kit (Zymo Research 497 R2050). An additional DNase step was performed after RNA extraction using a Turbo DNA-free kit (Thermo 498
Fisher Scientific AM1907). RNA yield was quantitated using a Qubit fluorimeter and 100 ng of total RNA was 499 used for cDNA synthesis in a 20-µl reaction using a High-Capacity cDNA Reverse Transcription Kit (Thermo 500
Fisher Scientific 4368814). Additional control reactions for each infected condition were performed without 501 reverse transcriptase enzyme to verify the efficiency of DNA removal from the samples. Three l of the 502 resulting cDNA was used in triplicate wells for RT-qPCR analysis. Primers for RT-qPCR are listed in Table 1 . were incubated with ice-cold virus dilutions at the indicated concentrations (normalized to 10 2 to 10 4 genome 511 copy numbers per cell as measured above by qPCR) at 4°C for 30 min. Cells were washed three times with ice-512 cold PBS to remove unbound virus, then bound virus was quantified using qPCR. Samples were analyzed in 513 triplicate and repeated three times. Briefly, genomic DNA was isolated from cell-bound KSHV using the 514 QIAamp Mini Elute Virus Spin Kit. The ratio of viral DNA to cellular DNA as a measurement of attached virus 515 was determined by qPCR as described above (FIG. 7) . The relative values of bound viral copy number to 516 cellular DNA were calculated on the basis of cycle threshold (ΔCt) values for viral genomic loci (K8.1) and a 517 cellular genomic locus (GAPDH). cells (iSLK rKSHV WT-eGFP, iSLK rKSHV∆gH-eGFP, or iSLK rKSHVgH-eGFP Rev) were induced into a 772 lytic cycle; the virus produced was purified and genome copy number was quantified using qPCR with KSHV 773 K8.1 primers (top panel), as compared to the absolute quantification standard curve obtained using pCAGGS-774
